Expression of a receptor for human macrophage-colony stimulating factor (M-CSF or CSF-1), containing a point mutation which changes an aspartate to a valine at position 802 of the activating loop of the kinase domain, potently transforms the haemopoietic cell line FDC-P1 yet prevents Rat-2 ®broblast transformation. In order to understand this apparent paradox, aspartate 802 was changed by cassette mutagenesis to each of the other 19 amino acids. All hydrophobic amino acid substitutions were transforming when tested in FDC-P1 cells yet inactivating when tested in Rat-2 ®broblasts. These same amino acid substitutions also activated receptor degradation, strongly suggesting a causal relationship between receptor degradation and inactivation in ®broblasts. Point mutations or small deletions of Y708 within the kinase insert region of the mutant D802V receptor partly inhibited receptor degradation. The more stable D802V receptor derivatives were able to transform both FDC-P1 cells and Rat-2 ®broblasts, so establishing that the cell speci®c eect of the c-fmsD802V activating loop mutation is attributable to receptor degradation which accompanies kinase activation and prevents the transformation of Rat-2 but not of FDC-P1 cells.
Introduction
The proto-oncogene c-fms encodes a tyrosine kinase receptor for macrophage colony stimulating factor (M-CSF or CSF-1), which is expressed both by monocytic cells and by cells of gynaecological origin (Sherr et al., 1985; Stanley et al., 1997) . Autocrine expression of M-CSF and its receptor is implicated in the genesis of leukaemia and of ovarian, uterine and breast tumours (Dubreuil et al., 1988; Rambaldi et al., 1988; Kacinski, 1997) .
Kinase activation in general is dependent upon the A or activating loop moving from an inactive to active conformation in order to uncover the kinase active site and to orientate key amino acids which catalyse substrate phosphorylation (see Johnson et al., 1996) . Recently, mutations of c-fms and the closely related proto-oncogene c-kit have been identi®ed that change equivalent aspartate residues to valine within the activating loops of the M-CSF and SCF receptors. These changes cause constitutive kinase activity (Glover et al., 1995; Kitayama et al., 1995) , probably by triggering the activating loop into an active conformation (Glover et al., 1995) . The c-fms mutation also causes constitutive receptor degradation, indicating that both signalling and degradation can be activated directly or indirectly by structural changes of the activating loop (Glover et al., 1995) .
Although the c-fmsD802V mutation is potently transforming in FDC-P1 cells, the same mutation actually prevents M-CSF from stimulating Rat-2 ®broblast foci formation (Glover et al., 1995) . Consequently the c-fmsD802V mutation is intriguing because it has an inactivating phenotype in ®broblasts yet is highly transforming in haemopoietic cells.
Activating mutations at dierent positions to c-fms and c-kit have also been found within the A loops of the RET and FGF receptors (Tavormina et al., 1995) . Both the RET and c-kitD814V activating loop mutations cause a shift in peptide phosphorylation speci®city of the receptors, which led to the suggestion that this may cause cell transformation through phosphorylation of inappropriate substrates (Songyang et al., 1995; Piao et al., 1996) . This raises the possibility that the cell speci®c eect of c-fmsD802V is due to altered receptor kinase speci®city. Another possibility is that the activation of receptor degradation by c-fmsD802V prevents ®broblast but not haemopoietic cell transformation (Glover et al., 1995) . Here, the molecular basis of the c-fmsD802V phenotype is explored.
Results
Asp 802 of the M-CSF receptor was replaced with the other 19 amino acids and the 20 dierent receptors were analysed in both the IL-3-dependent haemopoietic cell line FDC-P1 and Rat-2 ®broblasts. The 20 dierent receptors were separately introduced into these cells lines by retroviral infection under conditions where the majority of stably infected cells contain a single provirus, so ensuring uniform c-fms expression between infected cell populations (Dibb et al., 1990) . Receptor pairs with the same amino acid but dierent 802 codons were compared and gave similar results for all tested cases, as expected (data not shown).
Eect of receptor mutants upon cell growth
FDC-P1 cells that express normal c-fms can grow without IL-3 if M-CSF is present (Rohrschneider and Metcalf, 1989; Dibb et al., 1990) , whereas FDC-P1 cells that express fms oncogenes are transformed and can grow without both IL-3 and M-CSF (Wheeler et al., 1987) . In Figure 1a the amino acids at residue 802 of the mutant receptors are arranged in order of increasing hydrophobicity, this order reveals that the mutations of codon 802 fell into one of two broad categories. The ®rst category consisted of mutations (lys, thr, his, ala, cys, met, val, leu, ile, tyr, phe and trp) that strongly transformed FDC-P1 cells and generally encode amino acid substitutions that are either strongly or weakly hydrophobic (Hopp and Woods, 1981) . The only exception is Lys (Figure 1a) , although lysine is considered to be weakly hydrophobic in some classi®cation schemes because of its long hydrocarbon side chain (Sambrook et al., 1989) . The second category of mutations introduced non-hydrophobic amino acid substitutions that were either inactivating (Arg, Gln, Gly), neutral (Asn) or weakly activating (Glu, Ser, Pro). The phenotypic eect of these mutations are summarised in Table 1 . Figure 1b records the stimulation by M-CSF of colony growth in agar of Rat-2 ®broblasts that expressed a normal M-CSF (Asp802) receptor. Remarkably, the same category I mutations that strongly transformed FDC-P1 cells prevented the stimulation of growth of Rat-2 ®broblasts by M-CSF (Figure 1b) , so con®rming the previous paradoxical observations with the c-fmsD802V mutation (Glover et al., 1995) . The only mutations that allowed Rat-2 ®broblast growth in response to M-CSF were from category II (glu, ser, asn, pro) although the level of stimulation was consistently lower than normal ( Figure  1b ). These four category II mutant receptors could also stimulate FDC-P1 cell growth in response to M-CSF (data not shown) but either did not stimulate (asn) or only weakly stimulated (glu, ser, pro) FDC-P1 cell growth in the absence of M-CSF ( Figure 1a and Table  1 ). None of the 20 dierent receptors could stimulate the growth of Rat-2 ®broblasts colonies in the absence of M-CSF (data not shown). The amino acids Arg, Gln and Gly at residue 802 prevented M-CSF stimulation of growth of both FDC-P1 cells and Rat-2 ®broblasts.
Receptor expression
Two major glycosylated protein forms of the M-CSF receptor are normally found in cells and are referred to as immature and mature receptors, the immature form is further glycosylated to give the mature form which is found at the cell surface. The immature M-CSF Figure 1 The eect of amino acid changes of aspartate 802 of the M-CSFr upon the growth of FDC-P1 haemopoietic cells and Rat-2 ®broblasts. The two cell lines were infected separately with each of twenty c-fms retroviruses with the indicated single letter amino acid substitution at residue 802 of the M-CSF receptor and were also infected with the control retrovirus vsn2 alone, indicated by the number 2. The infected FDC-P1 cells were seeded at 5610 4 cells per ml in RPMI+10% FCS without IL-3 and without M-CSF and cell numbers/ml were counted after 8 days. Infected Rat-2 ®broblasts were plated at 1610 4 cells/ml in 0.75 ml of DMEM+10% FCS+5000 U/ml M-CSF in soft agar and total colony numbers were counted after 2 weeks. Error bars indicate the standard error of the mean from three separate experiments receptor is derived from the primary unglycosylated receptor protein via a series of precursor glycosylated proteins that are rapidly processed and so are not normally very evident but are sometimes seen for mutant receptors with defects in processing (Sherr et al., 1985; Rohrschneider and Metcalf, 1989) . Figure 2a shows the relative amount of each receptor expressed in Rat-2 ®broblasts. As expected, both the immature and mature receptors of 130 and 150 kD (top two arrows) are evident in lane 1 for the normal receptor. We previously reported that the mutant D802V receptor was rapidly degraded in Rat-2 ®broblasts and FDC-P1 cells (Glover et al., 1995) . In con®rmation of this, all of the category I mutant receptors were present in greatly reduced amounts, particularly D802W and D802V which were dicult to detect by this assay ( In order to compare the relative amounts of receptor expression at the cell surface, Rat-2 ®broblasts were biotinylated under conditions that only label exposed cell surface proteins (Meier et al., 1992) . These cells were then lysed and a Western blot was made from receptor immunoprecipitates and treated with a streptavidin : horseradish peroxidase conjugate which binds biotin. Figure 2c , lanes 6 and 9) were low but this is largely due to the small amount of receptor in the sample rather than to a defect in activity (data not shown).
Dierences in receptor steady state levels are due to receptor degradation Figure 3b , lane D) after this short labelling period. This indicates that the vast dierence in their steady state levels following 3 h labelling was not due to dierences in the rate at which the receptors were made and must therefore be attributable to receptor degradation. The Y and M mutant receptors labelled for 30 min were more easily seen than those labelled for 3 h. This is probably due both to a relative decrease in background over the shorter labelling period, and may also re¯ect an initial inhibition of protein degradation by the washing steps necessary for labelling.
Clonal cell lines also con®rmed the observation that the steady state levels of mutant D802V receptors were much lower than normal (Figure 3c ). In this experiment receptor expression was measured by in vitro autophosphorylation following immunoprecipitation because this was the most sensitive way to detect the mutant D802V receptors and was found previously to correlate well with receptor steady state levels (Glover et al., 1995) . Figure 3c (lanes 1 ± 3) shows autophosphorylation of a faint immature receptor band from 3 clonal cell lines that expressed cfmsD802V and were typical of 10 out of 12 that were analysed. Two out of 12 cell lines had higher levels of expression of D802V receptor, cell line 8 (lane 4) had the highest. However, the steady state D802V receptor level of cell line 8 was still considerably reduced compared to normal M-CSF receptor levels (lanes 5 to 8). Figure 2a and Figure 3a show that both the immature and mature receptor levels of many of the category I mutant receptors (for example lanes M and Y) were present in vastly reduced amounts compared to normal (lane D). Because the dierent receptors were made at a comparable rate (Figure 3 ) it follows that immature as well as mature mutant receptors were rapidly degraded. In support of this we found that, as expected, the glycosylation inhibitor castanospermine blocked the processing of the normal M-CSF receptor (Nichols et al., 1985) , but did not inhibit the degradation of mutant D802V receptors (data not shown). Figure 4a (lanes 1 ± 3) is a pulse-labelling study which demonstrates that most of the normal, immature 130 kD protein labelled in 30 min was converted to the mature form after a 90 min chase period ( Figure 4a , lane 2). The amount of mature form was reduced after 180 min chase (Figure 4a , lane 3), consistent with its known turnover rate in the absence of M-CSF (Rettenmier et al., 1987) . Figure  4a , lanes 4 ± 6 demonstrate that the addition of M-CSF accelerated receptor degradation as expected (see 4 ) and then chased for 90 min (lanes 2 and 5) or 180 min (lanes 3 and 6) with excess cold methionine in the absence (lanes 2 and 3) or presence (lanes 5 and 6) of 5000 U/ml M-CSF. (c) Lanes 2 ± 4 and 5 ± 7 show a pulse chase analysis of identical time points to A and B of the D802R and D802W receptors, respectively, in Rat-2 ®broblasts in the absence of M-CSF. Lane 1: normal M-CSF receptor labelled for 30 min Roth and Stanley, 1992) . Figure 4b shows that degradation of the mutant D802S receptor, which is representative of the category II mutants that are active, was similarly accelerated by the addition of M-CSF (Figure 4b , lanes 4 ± 6). Figure 5 shows the results of similar experiments in which the normal and mutant D802S receptors were labelled for 3 h prior to chasing over a 4 h period with or without M-CSF. The relative amounts of the mature receptor were determined by densitometry at each time point, the initial mature receptor amount was de®ned as 100%. This more detailed analysis shows that the D802S receptor had a noticeably shorter half-life (50 min) than normal (100 min) in the absence of M-CSF but the same half-life in its presence (30 min). Figure 4c , lanes 2 ± 4 show that the inactive D802R receptor accumulates as a glycosylated precursor protein of lower molecular weight than the immature receptor (Figure 4c , compare lanes 1 and 2) and is rapidly degraded during the chase period (irrespective of M-CSF addition), similar results were found for the D802G receptor (data not shown). The mutant D802W receptor, like the previously described D802V receptor (Glover et al., 1995) , was degraded far more rapidly than normal and had largely disappeared before the ®rst 90 min time point (Figure 4c lanes 5 ± 7 and see Figure 5 ). Similarly, all of the category I mutant receptors were degraded far more rapidly than normal in both FDC-P1 and Rat-2 cells, however, unlike normal receptors their degradation was not further enhanced by the addition of M-CSF (data not shown).
Eect of Asp802 to Val change upon v-fms function
The equivalent codon 802 of the oncogene v-fms was also mutated from asp to val and this was found to inhibit Rat-2 ®broblast transformation (Table 2) but to have no eect upon the transformation of FDC-P1 cells (data not shown). The v-fmsD802V mutation also enhanced the degradation of the v-Fms receptor (Figure 6a ), the chase time are longer in this experiment because the oncogenic v-Fms receptor is known to be processed more slowly than the normal cFms receptor (Roussel et al., 1998) .
Rat-2 transformation by a stable derivative of the D802V receptor
In order to determine if the accelerated degradation of the category I mutant receptors prevented their transformation of Rat-2 ®broblasts, attempts were made to generate a stable form of the D802V mutant receptor. Deletion of the kinase insert region stabilizes the normal receptor (Carlberg et al., 1991) . Figure 6b , lane 4 shows that a mutant D802V receptor with a kinase insert deletion has similar steady state levels to a normal M-CSF receptor (Figure 6b , lane 1) and that the immature and mature mutant receptors are smaller due to the deletion. By contrast the D802V receptor was barely detectable under similar conditions ( Figure  6b, lane 3) . However, mutant receptor D802V, DKI failed to transform Rat-2 ®broblasts (Table 2) . Because the autophosphorylation sites Y699 and Y723 are important for receptor activity in ®broblasts (Reedijk et al., 1990 (Reedijk et al., , 1992 van der Geer and Hunter, 1993) and were deleted by the DKI mutation, smaller deletions of this region were generated. One deletion, D706-12, Figure 5 Comparison of the degradation of the mature receptor of the wild type M-CSF receptor (fms), a category II mutant receptor (D802S) and a more stable derivative of the D802V receptor (DV708F) in the presence or absence of 5000 U/ml M-CSF. Rat-2 ®broblasts were labelled for 3 h with S 35 methionine and then chased with cold methionine for 1, 2, 3 or 4 h. Receptors were immunoprecipitated and analysed by SDS ± PAGE as described in the legend to Figure 4 . The amount of mature receptor was measured by densiotometry and plotted against the initial of amount of mature receptor after 3 h labelling which was de®ned as 100% Rat-2 cells described in A were plated in identical conditions apart from the addition of M-CSF to 5000 U/ml. *These colonies were consistently smaller than the c-fms colonies. Similar results were obtained in two other experiments removed seven amino acids including tyrosine 708 but not tyrosines 699 and 723. This mutant receptor was both more stable ( Figure 6 , lane 2) and showed a dramatic increase in the stimulation of Rat-2 ®broblast colony growth in soft agar in the absence of M-CSF (Table 2) , so establishing that activating mutations of codon 802 are capable of transforming ®broblasts but are prevented from doing so by their activation of receptor degradation. Both alanine (data not shown) and phenylalanine substitutions of Y708 also stabilized the D802V receptor ( Figure 6 , lane 5 ) and allowed Rat-2 ®broblast transformation (Table 2) with equal eectiveness as c-fmsD802V, D706-712. The 708F mutation was also made in a normal c-fms background and stimulated the proliferation of Rat-2 ®broblasts (Table 2) and FDC-P1 cells (data not shown) as eectively as a normal receptor and also produced a slight background in the absence of M-CSF (Table 2 ).
In the absence of M-CSF, mutant receptors D802V, D706-12 and D802V, Y708F were less transforming than the oncogene v-fms (Table 2) , and in the presence of M-CSF they were less stimulatory than the normal M-CSF receptor. It may be relevant that although the steady state levels of the mutant D802V receptor were greatly enhanced by deletion or mutation of Y708 (Figure 6b ), its cell surface expression was still considerably lower than normal (Figure 6c) . Because D802V,Y708F was far more stable than D802V (Figure 6b) we were able to measure the degradation rate of the mature receptor ( Figure 5) . The mature D802V, Y708F receptor was still degraded more rapidly than normal with a half-life of 30 min in the absence of M-CSF, which is the same as the degradation rate of a normal receptor in the presence of M-CSF and so accounts for its low cell surface expression and poor responsiveness to M-CSF ( Table  2 ). The addition of M-CSF did not further enhance the degradation of D802V, 708F (data not shown).
Discussion
Asp 802 is likely to be part of a key regulatory element of the tyrosine kinase domain of the M-CSF receptor because the two most potent activating mutations of cfms that we have so far selected in FDC-P1 cells following random mutagenesis change Asp802 to Val or to Tyr (Glover et al., 1995; unpublished) . Similarly, Val and Tyr substitutions of the equivalent Asp802 residue of the closely related c-Kit receptor have been reported in mast cell leukaemia (Kitayama et al., 1995; Tsujimura et al., 1995) . Here, we found that all hydrophobic amino acid substitutions of Asp802 of the M-CSFr were highly transforming. However, spontaneous transforming mutations of codon 802 of c-fms and probably of codon 814 of c-kit are likely to be restricted to val, tyr or ala because these are the only codons for hydrophobic amino acids that can be generated from an aspartate codon by a single base change. Only three amino acids (Gln, Arg and Gly) were inactivating, which is consistent with the location of residue 802 in a loop region with relatively little structural constraint. The normal amino acid Asp was best suited to position 802, allowing a strong growth stimulation in the presence of M-CSF yet no stimulation in its absence (Figure 1) .
Mechanism of receptor activation
The A helix of cAMP dependent protein kinase (cAPK) interacts with and stabilizes the active form of the activating loop (Veron et al., 1993) . In the active state, Arg190 of the activating loop of cAPK makes van der Waals contact with two hydrophobic amino acids of the A helix, Phe26 and the invariant Trp30 (Veron et al., 1993) . Asp802 of the M-CSF receptor is equivalent to Arg190 of cAPK which raises the possibility that Asp802 interacts with the hydrophobic amino acids Tyr571 and Trp575 of the A helix of the Asp 802 is in a region of the M-CSF receptor that corresponds to the 5 amino acid aL12 helix within the activating loop of inactive cyclin-dependent kinase CDK-2. One of the eects of cyclin binding is to melt aL12 into a b-strand (b9), which allows the CDK-2 activating loop to change to an active con®guration necessary for kinase activity (De Bondt et al., 1993; Jerey et al., 1995) . The highly transforming amino acid changes identi®ed here, with the possible exception of alanine, all have a greater propensity than aspartate to form b-sheets (Minor and Kim, 1994; Smith et al., 1994) . Consequently, hydrophobic substitutions of residue 802 of the M-CSF receptor may both trigger the activating loop into an active state and stabilise it.
Receptor degradation
All of the category I mutations that were highly transforming in FDC-P1 cells (Figure 1 ) greatly increased the degradation rate of both the immature and mature M-CSF receptor forms (Figures 2 ± 6), and therefore greatly reduced receptor cell surface expression in both FDC-P1 cells (Glover et al., 1995;  data not shown) and Rat-2 ®broblasts (Figure 2 ). The mutant receptors that were not strongly transforming (category II) included all of the more stable mutant receptors (Figure 2 ), although this category also includes the kinase-inactive mutant receptors D802G and D802R which were defective for processing and were very rapidly degraded. In addition, the mature form of the D802S receptor from category II was degraded more rapidly than normal in the absence of M-CSF (Figures 4 and 5) which probably accounts for its slightly lower steady state levels ( Figure 2 ) and may also explain the slightly lower steady state levels of the D802P and D802E receptors (Figure 2 ). However, in general, the category II mutant receptors were more stable and were degraded far less rapidly than the category I receptors (Figures 2 ± 6 ). It is normal for M-CSF receptors to be degraded following their activation by M-CSF (Li and Stanley, 1991) , the mutant receptors analysed here con®rm that receptor signalling and degradation can both be activated by structural changes of the activating loop (Glover et al., 1995) .
The steady state level of the mutant D802V receptor was increased many-fold by mutation of the autophosphorylation site Y708 (Figure 6 ), which is located within a large loop region of unknown structure called the kinase insert region. The mature receptor form of D802V, 708F was still degraded rapidly ( Figure 5 ) and so although its cell surface expression was higher than the unstable D802V receptor it was still low compared to normal (Figure 6 ). It would therefore appear that mutations of Y708 elevated D802V receptor levels largely by impairing the degradation of the immature receptor.
Y708 and the equivalent Y706 of the murine M-CSF receptor have been identi®ed as binding sites for STAT-1 (Novak et al., 1996) , although mutations of Y706 and of the equivalent residue of the oncogenic receptor vFms have little inhibitory eect upon cell proliferation in response to M-CSF (van der Geer and Hunter, 1991; Trouliaris et al., 1995) , which we also found for the human M-CSF receptor (Table 2 ). Y706 mutations were also reported to stabilize the murine M-CSF receptor (van der Geer and Hunter, 1991) , which is in accord with our results, although we were unable to see an obvious eect of the Y708 mutations alone upon the stability of the otherwise normal human M-CSF receptor (unpublished results). Curiously, glycine and phenylalanine substitutions of Y706 of the murine M-CSF receptor had slightly dierent eects upon the induction of early response genes and upon cell morphology in response to M-CSF, suggesting that these amino acid changes may have dierent structural eects (van der Geer and Hunter, 1991) . This raises the possibility that the eect of such mutations upon receptor stability also has a structural basis. Asp 802 of the M-CSFr is located in a region of the activating loop corresponding to the b9 strand of the insulin receptor (Hubbard, 1997) . We note that the amino acid sequence around Y708 and Y706 of the human and murine receptors (KKYVRRD) is similar to the b6 strand region of the insulin receptor (KKFVHRD), which packs tightly with the b9 strand of the active but not the inactive form of the insulin receptor (Hubbard, 1997) . However, the role of Y708 in in¯uencing receptor stability still remains to be determined.
Cell speci®c phenotype
There was a strict correlation between the activation of receptor degradation by c-fms802 mutations and their loss of transforming activity in Rat-2 ®broblasts, strongly suggesting a causal relationship. The fact that stable derivatives of the D802V receptor, with Ala or Phe substitutions or deletions of Y708, could transform ®broblasts largely establishes that the more rapid degradation of the D802V receptor prevents ®broblast transformation. By contrast, the rapid degradation of the D802V receptor in FDC-P1 cells (Glover et al., 1995 ; Fig 2d) did not prevent it from strongly transforming this cell type, so accounting for the widely dierent eect of the c-fmsD802V mutation in Rat-2 ®broblasts and FDC-P1 cells.
It still needs to be explained why the rapid degradation of D802V receptors has no or little inhibitory eect upon the transformation of FDC-P1 cells. There is evidence that cell surface expression of vFms is required for ®broblast transformation, possibly because v-Fms needs to activate key substrates at the cell membrane (Nichols et al., 1985; Roussel et al., 1984; Hadwiger et al., 1986) . The correlation between lack of cell surface expression of the mutant 802 receptors and their inability to transform ®broblasts is particularly strong (compare Figure 1 and Figure 2b) . Consequently, D802V receptors may not transform ®broblasts because their rapid degradation prevents sucient numbers from reaching the cell surface, which predicts that the expression of the D802V receptor at the cell surface is a less strict requirement for the transformation of FDC-P1 cells.
Materials and methods

Mutagenesis
Two enzyme sites BstXI and BsmI were introduced at positions 2682 and 2726 of the complete human cDNA of c-fms cloned in the retroviral construct vsn2 (Dibb et al., 1990) by oligo-directed mutagenesis in M13 using oligos GCCAAGATCTGTGACTTCGG and CAGCTGCCTGC-CAACGAGAAG. In addition a BstXI site at position 1456 of c-fms was removed by a neutral mutation using oligo AGAAACCCCGGCGGCTGGAG. Digestion of the now unique BstXI and BsmI sites removed a 45 bp region of the receptor¯anking the 802 codon. This region was then replaced by the cloning in of two complementary and overhanging oligos GGGGACTTCGGGCTGGCTAGGNN-NATCATGAATGACTCCAACTACA and TAGTTG-GAGTCATTCATGATNNNCCTAGCCAGCCCGAAGTC-CCCGATC which were equally degenerate at the 802 codon and which also restored the wild type amino acid sequence at the BstXI and BsmI cutting sites. D802X mutants were isolated and sequenced. One mutant not readily isolated D802M ± was made by oligo-directed mutagenesis with oligo CTGCCTAGGATGATCATGAAT. The retrovirus cfmsD802V,DKI was made by introducing a previously described in-frame deletion of bases 2356 ± 2529 of the kinase insert region of c-fms (Baker et al., 1994) . Smaller deletions of c-fmsD802V were made by linearising the cfmsD802V gene at the unique XhoI site at position 2410 of cfms and following the exonuclease III deletion protocol supplied with the Exo-Size deletion kit (NEB). The codon for Y708 (Coussens et al., 1986 ) of c-fms and c-fmsD802V was mutated to phenylalanine or alanine by oligo-directed mutagenesis with oligos GAGAAGAAATTCGTCCG-CAGG and GAGAAGAAAGCTGTCCGCAGG.
